TRK 700

Drug Profile

TRK 700

Alternative Names: TRK700

Latest Information Update: 07 Feb 2017

Price : $50

At a glance

  • Originator Toray Industries
  • Class Analgesics
  • Mechanism of Action Undefined mechanism
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes

Highest Development Phases

  • Phase II Postherpetic neuralgia

Most Recent Events

  • 01 Feb 2017 Toray Industries initiates a phase I drug-drug interaction trial in Healthy volunteers in Japan (PO) (NCT03043248)
  • 01 Mar 2016 Phase-II clinical trials in Postherpetic neuralgia (In adults, In the elderly) in Japan (PO)
  • 29 Feb 2016 Clinical trials in Postherpetic neuralgia in Japan (PO)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top